Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Àíåñòåçèîëîãèÿ è ìåäèöèíà êðèòè÷åñêèõ ñîñòîÿíèé

Àíåñòåçèîëîãèÿ è ìåäèöèíà êðèòè÷åñêèõ ñîñòîÿíèé Ôîðóìû: Àíåñòåçèîëîãèÿ, Èíòåíñèâíàÿ òåðàïèÿ â ïåäèàòðèè, Èíòåíñèâíàÿ òåðàïèÿ âçðîñëûõ, Âîïðîñû ïàöèåíòîâ.

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 01.12.2008, 18:12
Àâàòàð äëÿ Ravlentiy
Ravlentiy Ravlentiy âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.10.2008
Ãîðîä: Êèåâ
Ñîîáùåíèé: 18
Ñêàçàë(à) ñïàñèáî: 37
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Ravlentiy î ðåïóòàöèè ýòîãî ó÷àñòíèêà íåëüçÿ ñêàçàòü íè÷åãî îïðåäåëåííîãî
Àíàëãèí è Äåìèäðîë

Äîáðûé âå÷åð êîëëåãè.Ïîäñêàæèòå ïîæàëóéñòà èç êàêîãî ðîçùåòà Âû â ñâîåé ïðàêòèêå íàçíà÷àåòå(åñëè êîíå÷íî íàçíà÷àåòå)àíàëüãèí è äèìåäðîë â óíèâåðñèòåòå ãîâîðÿò ÷òî 0,1ìë íà ãîä æèçíè.Íî ÿ íå äóìàþ ÷òî òàêàÿ äîçà åôèêòèâíà íàïðèìåð ïðè òåìïåðàòóðå ó ðåáåíêà.Çàðàíèå ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 01.12.2008, 18:18
BBC BBC âíå ôîðóìà
ìîäåðàòîð ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 31,518
Ïîáëàãîäàðèëè 4,832 ðàç(à) çà 3,086 ñîîáùåíèé
BBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âîçìîæíî ñòîèò âñïîìíèòü, äëÿ íà÷àëà, ÷òî àíàëüãèí (òåì áîëåå â ñî÷åòàíèè ñ äèìåäðîëîì) íå âõîäèò íè â îäèí ñòàíäàðò îêàçàíèÿ ïîìîùè äåòÿì. Áîëåå òîãî, â öèâèëèçîâàííîì ìèðå îí çàïðåùåí ê ïðèìåíåíèþ ó äåòåé!
__________________
Ñ óâàæåíèåì,
Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 01.12.2008, 20:27
LupusDoc LupusDoc âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 04.08.2007
Ãîðîä: RUSSIA
Ñîîáùåíèé: 4,176
Ïîáëàãîäàðèëè 1,091 ðàç(à) çà 998 ñîîáùåíèé
LupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Ravlentiy Ïîñìîòðåòü ñîîáùåíèå
Äîáðûé âå÷åð êîëëåãè.Ïîäñêàæèòå ïîæàëóéñòà èç êàêîãî ðîçùåòà Âû â ñâîåé ïðàêòèêå íàçíà÷àåòå(åñëè êîíå÷íî íàçíà÷àåòå)àíàëãèí è äåìèäðîë â óíèâåðñèòåòå ãîâîðÿò ÷òî 0,1 íà ãîä æèçíè.Íî ÿ íå äóìàþ ÷òî òàêàÿ äîçà åôèêòèâíà íàïðèìåð ïðè òåìïåðàòóðå ó ðåáåíêà.Çàðàíèå ñïàñèáî.
Äëÿ íà÷àëà óòî÷íèòå íàïèñàíèå ïðåïàðàòîâ - àíàëÜãèí è äÈìÅäðîë,
âî-âòîðûõ, 0,1 ÷åãî?

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr.Nathalie îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 01.12.2008, 20:47
zubarew
Ãîñòü
 
Ñîîáùåíèé: n/a
Êñòàòè, êîãäà ìíå âíóòðèìûøå÷íî ââîäèëè äëÿ ïîñëåîïåðàöèîííîãî îáåçáîëèâàíèÿ àíàëüãèí ÿ ïîíÿë ñàêðàëüíûé ñìûñë åãî íàçíà÷åíèÿ. Óêîëû áûëè ñàìè ïî ñåáå íàñòîëüêî áîëåçíåííû, ÷òî î òîì, ÷òî ó òåáÿ ÷òî-òî áîëåëî äî ýòîãî ïðîñòî çàáûâàåøü.

Êîììåíòàðèè ê ñîîáùåíèþ:
birdname îäîáðèë(à): Ýòî òî÷íî. Òèïè÷íàÿ îòâëåêàþùàÿ òåðàïèÿ.
Dr.Nathalie îäîáðèë(à): â âåíó íåðàçâåäåííûì - áîëåå æåñòîêî! - óçíàåøü, ãäå ó òåáÿ ïîäêëþ÷è÷íàÿ âåíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 01.12.2008, 21:00
Àâàòàð äëÿ Ravlentiy
Ravlentiy Ravlentiy âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.10.2008
Ãîðîä: Êèåâ
Ñîîáùåíèé: 18
Ñêàçàë(à) ñïàñèáî: 37
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Ravlentiy î ðåïóòàöèè ýòîãî ó÷àñòíèêà íåëüçÿ ñêàçàòü íè÷åãî îïðåäåëåííîãî
Ìíîãîóâàæàåìûé Âàëåðèé Âàëåðüåâè÷ Âû áû íåìîãëè áû ìíå ñêèíóòü ññûëêó íà íîðìàòèâíûé àêò òàêîãîçàïðåòà íà àíàëüãèíþ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 01.12.2008, 21:03
Àâàòàð äëÿ Ravlentiy
Ravlentiy Ravlentiy âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.10.2008
Ãîðîä: Êèåâ
Ñîîáùåíèé: 18
Ñêàçàë(à) ñïàñèáî: 37
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Ravlentiy î ðåïóòàöèè ýòîãî ó÷àñòíèêà íåëüçÿ ñêàçàòü íè÷åãî îïðåäåëåííîãî
Öèòàòà:
Ñîîáùåíèå îò LupusDoc Ïîñìîòðåòü ñîîáùåíèå
Äëÿ íà÷àëà óòî÷íèòå íàïèñàíèå ïðåïàðàòîâ - àíàëÜãèí è äÈìÅäðîë,
âî-âòîðûõ, 0,1 ÷åãî?
Èçâèíèòå çà ìîþ áåãðàìîòíîñòü ÿ Âàì î÷åíü áëàãîäàðèí çà ïîïðàâêó à äîçà 0.1 ìë
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 01.12.2008, 21:07
Àâàòàð äëÿ Ravlentiy
Ravlentiy Ravlentiy âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.10.2008
Ãîðîä: Êèåâ
Ñîîáùåíèé: 18
Ñêàçàë(à) ñïàñèáî: 37
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
Ravlentiy î ðåïóòàöèè ýòîãî ó÷àñòíèêà íåëüçÿ ñêàçàòü íè÷åãî îïðåäåëåííîãî
Íåìîãëè áû Âû ïðîïèñàòü ññûëî÷êó íà íîðìàòèâíûé àêò êîòîðûé çàïðèùÿåò èñïîëüçûâàíèå àíàëüãèíà
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 01.12.2008, 21:16
Rodionov Rodionov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 28.02.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 9,764
Ïîáëàãîäàðèëè 804 ðàç(à) çà 733 ñîîáùåíèé
Rodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåRodionov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ß òàê ïîíèìàþ, ÷òî àíãëèéñêèé â Êèåâå óæå çíàþò ëó÷øå, ÷åì ðóññêèé.
À ïîñêîëüêó Îìåðèêà è Óêðàèíà - áõàé-áõàé, òî ïîëó÷èòå îìåðèêàíñêèå íîðìàòèâíûå äîêóìåíòû:
Öèòàòà:
Pharmacotherapy. 2006 Mar;26(3):440-2.Click here to read Links
Dipyrone-induced granulocytopenia: a case for awareness.
Garcia S, Canionero M, Lopes G.

Dipyrone, also known as metamizole, is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with agranulocytosis. However, it is still produced and marketed in several countries in Central and South America as well as in Europe, Asia, and Africa. It can also be found in the United States, where illegal sales have been reported in California gift shops, markets, bakeries, and other retail establishments. Dipyrone is commonly found in the homes of families who are originally from areas where it is still lawfully marketed. We describe a patient who developed granulocytopenia and fever after taking dipyrone and discuss the available literature. Our aim is to raise awareness of this drug, which is commonly used outside the United States, and to call attention to its well-known and potentially lethal side effect.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 01.12.2008, 21:28
LupusDoc LupusDoc âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 04.08.2007
Ãîðîä: RUSSIA
Ñîîáùåíèé: 4,176
Ïîáëàãîäàðèëè 1,091 ðàç(à) çà 998 ñîîáùåíèé
LupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Ravlentiy Ïîñìîòðåòü ñîîáùåíèå
Íåìîãëè áû Âû ïðîïèñàòü ññûëî÷êó íà íîðìàòèâíûé àêò êîòîðûé çàïðèùÿåò èñïîëüçûâàíèå àíàëüãèíà
Äàâàéòå ÿ ëó÷øå âìåñòî íîðìàòèâíûõ àêòîâ Âàì ññûëî÷åê äàì íà ïóáëèêàöèè ïî áåçîïàñíîñòè àíàëüãèíà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

è ýòî äàëåêî íå âñå...

Ìîæíî òàêæå âîñïîëüçîâàòüñÿ ïîèñêîì ïî ôîðóìó, ÷òîáû íàéòè îáñóæäåíèÿ àíàëüãèíà è ïî÷åìó îí äàâíî çàïðåùåí â áîëüøèíñòâå ñòðàí ìèðà.

Êîììåíòàðèè ê ñîîáùåíèþ:
riltsov îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 01.12.2008, 21:30
BBC BBC âíå ôîðóìà
ìîäåðàòîð ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 31,518
Ïîáëàãîäàðèëè 4,832 ðàç(à) çà 3,086 ñîîáùåíèé
BBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êñòàòè, â ñåòè åñòü çàìå÷àòåëüíàÿ ïåðåâîäíàÿ êíèæêà, î÷åíü õîðîøî ðàñêðûâàþùàÿ ãëàçà (ñïåðâà íàïèñàë "ïðî÷èùàþùàÿ ìîçãè", ïîòîì èñïðàâèë íà áîëåå êîððåêòíîå) Èñêðåííå ðåêîìåíäóþ Ýíäðþ ×åòëè "ïðîáëåìíûå ëåêàðñòâà" [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Õîòÿ, ñòðîãî ïî òåêñòó Âû ïðàâû - à Ðîññèè àíàëüãèí ïî-ïðåæíåìó ðàçðåøåí....

Êîììåíòàðèè ê ñîîáùåíèþ:
LupusDoc îäîáðèë(à): È ðàçðåøåííàÿ äîçà 5-10 ìã/êã ìàññû òåëà
Vlad34 îäîáðèë(à): Î÷åíü çàíèìàòåëüíàÿ êíèãà, ñêà÷àë îòñþäà http://www.u-mama.ru/files/books/andru.rar, óíåñ íà ðàáîòó
__________________
Ñ óâàæåíèåì,
Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 07.12.2008, 14:20
Shahla Shahla âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 10.04.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 1,731
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Shahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûå êîëëåãè, óâàæàåìûé Lupus Doc.
Ìåòàìèçîë çàïðåùåí â USA, íî îí íå çàïðåùåí â Åâðîïå. Êàê ìíå ñêàçàëè íà ìîåé íîâîé ðàáîòå (íå áåç âàøåé ïîìîùè, óâàæàåìûé LupusDoc) ïî ðåãèñòðàöèè ëåêàðñòâ, ìåòàìèçîë çàïðåùåí òîëüêî â äâóõ åâðîïåéñêèõ ñòðàíàõ, è ÷òî ýòî èçâå÷íàÿ âîéíà àíàëüãèíà ñ ïàðàöåòàìîëîì. Íåñìîòðÿ íà æåñòêèé êîíòðîëü FDA, â àìåðèêàíñêîì ñïðàâî÷íèêå PDR Physician Desk Reference ÿ íå íàøëà, íàïðèìåð, àìïèöèëëèíà, íî çàòî â êîíöå òàì áûë âíóøèòåëüíûé ñïèñîê ïèùåâûõ äîáàâîê.

Ïîíèìàþ, ÷òî ïðèâîæó ìíåíèå îòäåëüíîãî ýêñïåðòà, íî àêàä. À.È. Âîðîáåâ â ãàçåòå "Ìîñêîâñêèé äîêòîð" ñ÷èòàåò ïàðàöåòàìîë îïàñíûì ëåêàðñòâîì è ãîâîðèò, ÷òî äîëãî áîðîëñÿ ïðîòèâ çàêóïîê ïàðàöåòàìîëà Ðîññèåé. Ìîãó óêàçàòü íîìåð ãàçåòû.
 ïîäòâåðæäåíèå ñëîâ ïðèâîæó ññûëêó:

...À âîò èíåòåðåñíî, ïîêà âî ìíîãèõ ñòðàíàõ àíàëüãèí çàïðåùàþò è ïðåäóïðåæäàþò î åãî ïîáî÷íûõ ýôôåêòàõ, ÂÎÇ òåì âðåìåíåì ïóáëèêóåò òàêèå âîò äàííûå:
These studies certainly suggest that the risks from adverse reactions to metamizole are similar to those posed by paracetamol, a drug widely reputed to be safe. According to the CIOMS IV conclusion “Newer methods of epidemiological studies have shown that the risk of agranulocytosis (1.7 per million) due to metamizole was exaggerated in the 70’s” (9).
A randomized, double blind, multinational study involving 555 children showed that metamizole and ibuprofen were significantly more effective than paracetamol in achieving normal body temperatures; metamizole produced a significantly greater temperature reduction than ibuprofen and paracetamol, and helped maintain low tempera-tures for a longer duration(11). An editorial on the report from this study commented that drugs such as metamizole were perhaps unjustly deleted from our pharmacopoeia because of imprecise studies of adverse side effect; some of the older therapeutic agents such as metamizole may be identified as having clinical utility in children(12 ,
âçÿòóþ îòñþäà http://forums.rusmedserv.com/showthr...EB%FC%E3%E8%ED

À ïàðàöåòàìîë äåéñòâèòåëüíî ãîðàçäî ñëàáåå àíàëüãèíà ñíèæàåò òåìïåðàòóðó, ýòî ÿ äàâíî çàìåòèëà.

Êîììåíòàðèè ê ñîîáùåíèþ:
Valeriy îäîáðèë(à):
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà.
Òåðàïåâò, ïóëüìîíîëîã.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 07.12.2008, 15:34
LupusDoc LupusDoc âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 04.08.2007
Ãîðîä: RUSSIA
Ñîîáùåíèé: 4,176
Ïîáëàãîäàðèëè 1,091 ðàç(à) çà 998 ñîîáùåíèé
LupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Shahla Ïîñìîòðåòü ñîîáùåíèå
Óâàæàåìûå êîëëåãè, óâàæàåìûé Lupus Doc.
Ìåòàìèçîë çàïðåùåí â USA, íî îí íå çàïðåùåí â Åâðîïå. Êàê ìíå ñêàçàëè íà ìîåé íîâîé ðàáîòå (íå áåç âàøåé ïîìîùè, óâàæàåìûé LupusDoc) ïî ðåãèñòðàöèè ëåêàðñòâ, ìåòàìèçîë çàïðåùåí òîëüêî â äâóõ åâðîïåéñêèõ ñòðàíàõ, è ÷òî ýòî èçâå÷íàÿ âîéíà àíàëüãèíà ñ ïàðàöåòàìîëîì.
Àíàëüãèí, äåéñòâèòåëüíî, ðàçðåøåí â íåñêîëüêèõ ñòðàíàõ Åâðîïû - ýòî ñòðàíû Âîñòî÷íîé Åâðîïû (íî íå âñå, íàïðèìåð, íåäàâíî Ëèòâà çàïðåòèëà èñïîëüçîâàíèå ìåòàìèçîëà), Èñïàíèÿ è Ïîðòóãàëèÿ - áåçðåöåïòóðíî, Ãåðìàíèÿ - ðåöåïòóðíî, ñ óêàçàíèåì "èñïîëüçîâàòü â èñêëþ÷èòåëüíûõ ñëó÷àÿõ". Íî ýòî íå ãîâîðèò î òîì, ÷òî àíàëüãèí áåçîïàñåí.

Öèòàòà:
Ïîíèìàþ, ÷òî ïðèâîæó ìíåíèå îòäåëüíîãî ýêñïåðòà, íî àêàä. À.È. Âîðîáåâ â ãàçåòå "Ìîñêîâñêèé äîêòîð" ñ÷èòàåò ïàðàöåòàìîë îïàñíûì ëåêàðñòâîì è ãîâîðèò, ÷òî äîëãî áîðîëñÿ ïðîòèâ çàêóïîê ïàðàöåòàìîëà Ðîññèåé. Ìîãó óêàçàòü íîìåð ãàçåòû.
 ïîäòâåðæäåíèå ñëîâ ïðèâîæó ññûëêó:

...À âîò èíåòåðåñíî, ïîêà âî ìíîãèõ ñòðàíàõ àíàëüãèí çàïðåùàþò è ïðåäóïðåæäàþò î åãî ïîáî÷íûõ ýôôåêòàõ, ÂÎÇ òåì âðåìåíåì ïóáëèêóåò òàêèå âîò äàííûå:
These studies certainly suggest that the risks from adverse reactions to metamizole are similar to those posed by paracetamol, a drug widely reputed to be safe. According to the CIOMS IV conclusion “Newer methods of epidemiological studies have shown that the risk of agranulocytosis (1.7 per million) due to metamizole was exaggerated in the 70’s” (9).
A randomized, double blind, multinational study involving 555 children showed that metamizole and ibuprofen were significantly more effective than paracetamol in achieving normal body temperatures; metamizole produced a significantly greater temperature reduction than ibuprofen and paracetamol, and helped maintain low tempera-tures for a longer duration(11). An editorial on the report from this study commented that drugs such as metamizole were perhaps unjustly deleted from our pharmacopoeia because of imprecise studies of adverse side effect; some of the older therapeutic agents such as metamizole may be identified as having clinical utility in children(12 ,
âçÿòóþ îòñþäà http://forums.rusmedserv.com/showthr...EB%FC%E3%E8%ED
Ýòà ïóáëèêàöèÿ ÍÅ ÎÒÐÀÆÀÅÒ ïîçèöèþ ÂÎÇ. Áóêâàëüíî â ñëåäóþùåì íîìåðå:
Öèòàòà:
In the last issue of the newsletter we published an article on the use of
metamizole sodium in Brazil. Some of our readers have expressed
reservations about the article. We reiterate that the article on
metamizole does not, in any way, reflect WHO’s position on the drug.

The intention was to open a debate on the need for continued
monitoring of older generic drugs and to remind our readers of the
necessity always to compare safety with similar products on the market.
We now invite specific comments to the article and would be pleased to
publish those and other concerns in the next issue of our newsletter.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Ìåòàìèçîë ÍÅ âêëþ÷åí â ñïèñîê Essential Drugs, ÍÅ ðåêîìåíäîâàí ÂÎÇ ê èñïîëüçîâàíèþ.

Öèòàòà:
À ïàðàöåòàìîë äåéñòâèòåëüíî ãîðàçäî ñëàáåå àíàëüãèíà ñíèæàåò òåìïåðàòóðó, ýòî ÿ äàâíî çàìåòèëà.
Ìîæåò áûòü, òîëüêî âîïðîñ à íóæíî ëè ñíèæàòü òåìïåðàòóðó ñèëüíåå, ÷åì ýòî äåëàåò ïàðàöåòàìîë?
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 07.12.2008, 16:04
Dr. Nika Dr. Nika âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 19.01.2007
Ãîðîä: Ýôèîïèÿ
Ñîîáùåíèé: 2,221
Ïîáëàãîäàðèëè 423 ðàç(à) çà 411 ñîîáùåíèé
Dr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. Nika ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
È âñå-òàêè ÂÎÇ íå îïðåäåëèëñÿ ñî ñâîåé ïîçèöèåé â îòíîøåíèè àíàëüãèíà.
Îíè îñòîðîæíè÷àþò.
Äåëî â òîì, ÷òî ïîñëå òîãî, êàê øâåäàìè áûëî çàÿâëåíî, ÷òî ïðèìåíåíèå àíàëüãèíà ïîâûøàåò ðèñê ðàçâèòèÿ àãðàíóëîöèòîçà, áûëî ïðîâåäåíî áîëüøîå èññëåäîâàíèå International Agranulocytosis and Aplastic Anaemia (IAAA), ãäå ïîêàçàëè, ÷òî ðèñê ðàçâèòèÿ àãðàíóëîöèòîçà ïðè ïðèìåíåíèè àíàëüãèíà ñâîäèòñÿ ê 1.1 íà ìèëëèîí. Ïîñëå ýòîãî àíàëüãèí âíîâü áûë ðàçðåøåí ê ïðèìåíåíèþ, íî øâåäû âíîâü âçÿëèñü çà èññëåäîâàíèÿ è âíîâü çàÿâèëè, ÷òî ðèñê ãîðàçäî âûøå, êàê ìèíèìóì 1 ê 1439, ÷òî ïðèâåëî ê ïîâòîðíîìó çàïðåòó àíàëüãèíà.
Íî âîò â ÷åì çàãâîçäêà - íå îñòàëñÿ îòâå÷åííûì âîïðîñ, ïî÷åìó òàêàÿ ðàçíèöà â ðåçëóüòàòàõ? Òî ëè ó ñêàíäèíàâîâ åñòü ãåíåòè÷åñêàÿ ïðåäðàñïîëîæåííîñòü ê òàêîé ðåàêöèè, è ïîòîìó èìåííî â øâåäñêèõ èññëåäîâàíèÿõ òàêîé âûñîêèé ðèñê îïðåäåëÿåòñÿ, òî ëè International Agranulocytosis and Aplastic Anaemia ñîâåðøåííî íåïðàâèëüíî ïðîâåëè èññëåäîâàíèå.
 èòîãå ÂÎÇ ïðîñòî ðåøèë ïîêà îòëîæèòü âûâîäû, ïîêà íå áóäóò ïðîâåäåíû îïÿòü èññåëåäîâàíèÿ, íî òîëüêî íà ýòî ðàç íå â ñêàíäèíàâñêèõ ñòðàíàõ.

"The present publication provides evidence for the claims of a high risk of agranulocytosis with metamizole in Swedish patients. The study does not, however, clarify whether Scandinavians are genetically at a greater risk for such reactions. Comparative studies in various countries with more diverse. issue further and until this data is available, other drugs should be considered as first-line analgesics."

Íî çàìåòüòå, íåò íè ñëîâà î ïîëíîì çàïðåòå, åñòü òîëüêî âûâîä î ïðåïàðàòàõ âûáîðà ïåðâîé ëèíèè.

WHO Pharmaceuticals Newsletter No. 3, 2002  18 ( â ñåòè åñòü)

Êîììåíòàðèè ê ñîîáùåíèþ:
thorn îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 23.12.2008, 13:44
Àâàòàð äëÿ bnimail
bnimail bnimail âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 19.12.2008
Ãîðîä: Ìèíñê
Ñîîáùåíèé: 19
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
bnimail ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò LupusDoc Ïîñìîòðåòü ñîîáùåíèå
Ìîæåò áûòü, òîëüêî âîïðîñ à íóæíî ëè ñíèæàòü òåìïåðàòóðó ñèëüíåå, ÷åì ýòî äåëàåò ïàðàöåòàìîë?
Âîïðîñ õîðîøèé. Íî íå èìåþùèé, íà ìîé âçãëÿä, øàíñîâ íà ñêîëü-íèáóäü íàó÷íîîáîñíîâàííûé îòâåò
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 23.12.2008, 19:52
LupusDoc LupusDoc âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 04.08.2007
Ãîðîä: RUSSIA
Ñîîáùåíèé: 4,176
Ïîáëàãîäàðèëè 1,091 ðàç(à) çà 998 ñîîáùåíèé
LupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò bnimail Ïîñìîòðåòü ñîîáùåíèå
Âîïðîñ õîðîøèé. Íî íå èìåþùèé, íà ìîé âçãëÿä, øàíñîâ íà ñêîëü-íèáóäü íàó÷íîîáîñíîâàííûé îòâåò
Ýòî ïî÷åìó
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 08:23.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.